CO6450642A2 - Métodos para tratar una infección bacteriana pulmonar utilizando fluoro-quinolonas - Google Patents

Métodos para tratar una infección bacteriana pulmonar utilizando fluoro-quinolonas

Info

Publication number
CO6450642A2
CO6450642A2 CO11148624A CO11148624A CO6450642A2 CO 6450642 A2 CO6450642 A2 CO 6450642A2 CO 11148624 A CO11148624 A CO 11148624A CO 11148624 A CO11148624 A CO 11148624A CO 6450642 A2 CO6450642 A2 CO 6450642A2
Authority
CO
Colombia
Prior art keywords
methods
bacterial infection
quinolones
fluoro
treat
Prior art date
Application number
CO11148624A
Other languages
English (en)
Inventor
Mike Dudley
David Griffith
Olga Rodny
Original Assignee
Mpex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43011488&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6450642(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mpex Pharmaceuticals Inc filed Critical Mpex Pharmaceuticals Inc
Publication of CO6450642A2 publication Critical patent/CO6450642A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Se describen en la presente métodos para tratar una infección bacteriana pulmonar que comprende el desarrollo de bacterias bajo condiciones anaeróbicas utilizando un antibiótico de fluoroquinolona. El antibiótico de fluoroquinolona puede por ejemplo, ser levofloxacina o ofloxacina. También se describen métodos para inhibir el desarrollo de bacterias bajo condiciones anaeróbicas al exponer las bacterias a una cantidad de antibiótico de fluoroquinolona efectiva para inhibir el desarrollo de dichasbacterias.
CO11148624A 2009-04-24 2011-11-02 Métodos para tratar una infección bacteriana pulmonar utilizando fluoro-quinolonas CO6450642A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17262509P 2009-04-24 2009-04-24

Publications (1)

Publication Number Publication Date
CO6450642A2 true CO6450642A2 (es) 2012-05-31

Family

ID=43011488

Family Applications (1)

Application Number Title Priority Date Filing Date
CO11148624A CO6450642A2 (es) 2009-04-24 2011-11-02 Métodos para tratar una infección bacteriana pulmonar utilizando fluoro-quinolonas

Country Status (27)

Country Link
US (2) US20120035166A1 (es)
EP (1) EP2421539B1 (es)
JP (2) JP6179844B2 (es)
KR (1) KR20120034626A (es)
CN (2) CN102427815A (es)
AU (1) AU2010238765B2 (es)
BR (1) BRPI1006626B8 (es)
CA (1) CA2759874C (es)
CL (1) CL2011002649A1 (es)
CO (1) CO6450642A2 (es)
CY (1) CY1122525T1 (es)
DK (1) DK2421539T3 (es)
ES (1) ES2755754T3 (es)
HR (1) HRP20191951T1 (es)
HU (1) HUE046595T2 (es)
IL (1) IL215777A (es)
LT (1) LT2421539T (es)
MX (1) MX339077B (es)
MY (1) MY178871A (es)
NZ (1) NZ596245A (es)
PL (1) PL2421539T3 (es)
PT (1) PT2421539T (es)
RU (1) RU2535056C2 (es)
SG (3) SG10201811494SA (es)
SI (1) SI2421539T1 (es)
WO (1) WO2010124141A1 (es)
ZA (1) ZA201107903B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8524734B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
JP2012505222A (ja) 2008-10-07 2012-03-01 エムペックス・ファーマシューティカルズ・インコーポレーテッド 肺炎症を低減するためのレボフロキサシンの吸入
LT2344129T (lt) 2008-10-07 2018-05-10 Horizon Orphan Llc Aerozolinės fluorchinolono kompozicijos, skirtos farmakokinetikų pagerinimui
BR112012004692B8 (pt) 2009-09-04 2021-05-25 Mpex Pharmaceuticals Inc solução que compreende levofloxacina para uso em um método para tratar a fibrose cística em um ser humano
US9572774B2 (en) 2011-05-19 2017-02-21 Savara Inc. Dry powder vancomycin compositions and associated methods
WO2014152326A1 (en) * 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
JP6966835B2 (ja) * 2016-02-05 2021-11-17 ホライズン オーファン リミテッド ライアビリティ カンパニー 嚢胞性線維症のためのフルオロキノロン製剤
CN108849939B (zh) * 2018-07-31 2021-02-19 广东省农业科学院植物保护研究所 盐酸左氧氟沙星在制备用于防治烟草青枯病的农药制剂中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040009126A1 (en) 2002-03-05 2004-01-15 Transave, Inc. Inhalation system for prevention and treatment of intracellular infections
RU2255757C1 (ru) * 2004-06-22 2005-07-10 Санкт-Петербургская Общественная Организация "Санкт-Петербургский Институт Биорегуляции И Геронтологии Сзо Рамн" Пептидное соединение, восстанавливающее функцию органов дыхания
CA2608273C (en) * 2005-05-18 2015-10-20 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US7838532B2 (en) 2005-05-18 2010-11-23 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
EP2285345A1 (en) 2008-05-15 2011-02-23 Novartis AG Pulmonary delivery of a fluoroquinolone
LT2344129T (lt) 2008-10-07 2018-05-10 Horizon Orphan Llc Aerozolinės fluorchinolono kompozicijos, skirtos farmakokinetikų pagerinimui

Also Published As

Publication number Publication date
AU2010238765B2 (en) 2014-12-18
RU2011145430A (ru) 2013-05-27
IL215777A (en) 2017-09-28
EP2421539A1 (en) 2012-02-29
SG10201811494SA (en) 2019-01-30
SG10201403512TA (en) 2014-08-28
CY1122525T1 (el) 2021-01-27
BRPI1006626A2 (pt) 2020-07-28
CA2759874A1 (en) 2010-10-28
SI2421539T1 (sl) 2019-12-31
JP2016053041A (ja) 2016-04-14
JP2012524811A (ja) 2012-10-18
HUE046595T2 (hu) 2020-03-30
IL215777A0 (en) 2012-01-31
HRP20191951T1 (hr) 2021-05-14
RU2535056C2 (ru) 2014-12-10
DK2421539T3 (da) 2019-11-18
JP6228580B2 (ja) 2017-11-08
MY178871A (en) 2020-10-21
AU2010238765A1 (en) 2011-11-10
NZ596245A (en) 2013-11-29
KR20120034626A (ko) 2012-04-12
CL2011002649A1 (es) 2012-06-22
MX339077B (es) 2016-05-10
WO2010124141A1 (en) 2010-10-28
BRPI1006626B1 (pt) 2021-05-11
PT2421539T (pt) 2019-11-22
LT2421539T (lt) 2019-12-10
BRPI1006626B8 (pt) 2021-05-25
JP6179844B2 (ja) 2017-08-16
ES2755754T3 (es) 2020-04-23
SG175288A1 (en) 2011-11-28
US20120035166A1 (en) 2012-02-09
CA2759874C (en) 2016-11-08
CN102427815A (zh) 2012-04-25
MX2011011190A (es) 2012-02-13
EP2421539A4 (en) 2014-01-29
EP2421539B1 (en) 2019-10-23
ZA201107903B (en) 2013-01-30
US20210015811A1 (en) 2021-01-21
CN107050032A (zh) 2017-08-18
PL2421539T3 (pl) 2020-02-28

Similar Documents

Publication Publication Date Title
CO6450642A2 (es) Métodos para tratar una infección bacteriana pulmonar utilizando fluoro-quinolonas
PH12016501577A1 (en) Monobactam organic compounds for the treatment of bacterial infections
MY174523A (en) ?-lactamase inhibitor and process for preparing the same
ECSP11010980A (es) Compuestos heteroaromáticos espirocíclicos fusionados para el tratamiento de infecciones bacterianas
NZ593111A (en) Antibacterial compounds
EP3409666A3 (en) Seca inhibitors and methods of making and using thereof
MX2011011735A (es) Compuestos y metodos para la inhibicion de renina, e indicaciones para ello.
ECSP10010345A (es) Inhibidores de beta-lactamasa
CO2017005870A2 (es) Compuestos de isoxazol de ácido hidroxámico como inhibidores de lpxc
NZ708928A (en) Mannose derivatives for treating bacterial infections
CO2019002624A2 (es) Compuestos antibióticos
EA201100874A1 (ru) Соединения для лечения рака
EA201390639A1 (ru) Производные 2-пиперазин-1-ил-4н-1,3-бензотиазин-4-она и их применение для лечения инфекций у млекопитающих
WO2012103295A3 (en) Small molecule rnase inhibitors and methods of use
MA32375B1 (fr) Derives de 5-hydroxymethyl-oxazolidine-2-one pour le traitement de maladies intestinales bacteriennes
EA201170121A1 (ru) Лечение инфекций, вызванных антибиотикоустойчивыми бактериями
CL2022001042A1 (es) Bacterias productoras de serotonina
BR112021023169A2 (pt) Métodos e composições para fermentação bacteriana anaeróbica
CR10998A (es) Macrolidos
BR112017008101A2 (pt) composto, composição farmacêutica, métodos para inibir o dnae bacteriano e para tratar uma infecção, e, uso de um composto.
NO20101313L (no) Fremgangsmate for a hemme bakterievekst
ECSP18060284A (es) Tratamiento para microorganismos que contienen quitina
AR087586A1 (es) Sistema enzimatico
JO3477B1 (ar) مركبات أحادي باكتام عضوية لعلاج العدوى البكتيرية
CO2018006715A2 (es) Proceso para la inducción de actividad antimicrobiana en bacterias aerobias formadoras de endospora

Legal Events

Date Code Title Description
FC Application refused